Screening Adolescents for Type 2 Diabetes Mellitus in a Community Clinic
1 other identifier
interventional
400
1 country
1
Brief Summary
The purpose of this study is to evaluate the prevalence of Type 2 diabetes or impaired glucose tolerance in a subset of children 10-19 years of age in an inner city community clinic. The demographics of the clinic are 75% African American, 20% Hispanic, 5% other. African American and Hispanic patients have a higher prevalence of diabetes with significant morbidity, predominantly from microvascular and macrovascular disease. Obesity is commonly seen in patients with Type 2 diabetes and contributes to the underlying insulin resistance seen in the disease. Obesity is an increasing health problem among adolescents. Since Type 2 diabetes can be present for several years before diagnosis, it is worrisome that younger children will have undiagnosed Type 2 diabetes for years. This will increase the risk of earlier complications in these patients as young adults. We hypothesize that the occurrence of abnormal glucose metabolism in 400 children with either a history of obesity, family history of diabetes mellitus, or symptoms suggestive of diabetes mellitus will be higher than the general pediatric population. We believe that a family based educational program can reduce fasting plasma glucose.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable diabetes-mellitus
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 22, 2002
CompletedFirst Posted
Study publicly available on registry
July 23, 2002
CompletedJune 24, 2005
July 1, 2002
July 22, 2002
June 23, 2005
Conditions
Interventions
Eligibility Criteria
You may qualify if:
- % of ideal body weight or BMI\> 27
- Weight greater than 75th percentile
- Family history of type 2 diabetes in first or second degree relative
- Acanthosis nigricans or skin tags as signs of insulin resistance
- Symptoms of hyperglycemia (polyuria, polydipsia, polyphagia, or recurrent infections).
- Symptoms or signs of PCOS (hyperandrogenism, hirsutism, irregular menses)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- National Center for Research Resources (NCRR)lead
- Duke Universitycollaborator
- Diabetes Trust Fundcollaborator
Study Sites (1)
Duke University
Durham, North Carolina, 27710, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- ECT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- NIH
Study Record Dates
First Submitted
July 22, 2002
First Posted
July 23, 2002
Last Updated
June 24, 2005
Record last verified: 2002-07